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Expression Pro®le of Connexins in Human Epidermis
What is the connecting link between such clinically disparate skin
disorders as erythrokeratodermia variabilis (EKV), palmoplantar
keratoderma (PPK), and hidrotic ectodermal dysplasia (HED)? The
answer: Faulty gap junction proteins known as connexins.
Speci®cally, these disorders are caused by dominant mutations in
connexin genes, including Cx31 and Cx30.3 in EKV, Cx26 in
PPK associated with hearing impairment, and Cx30 in HED.
Connexins are a large family of over 20 proteins that form gated,
aqueous gap junction channels between adjoining cells, thus
permitting the rapid exchange of ions, small metabolites, and
signaling molecules. In skin, gap junction-mediated intercellular
communication seems vital for establishing and maintaining
homeostasis of the epidermis, and critical for controlled and
synchronized division, differentiation, and desquamation, as well as
migration of keratinocytes.
In this issue, Di et al (p. 958) provide us with a road map of
connexin expression in human epidermis. The authors system-
atically analyzed the expression and distribution of epidermal
connexins in interfollicular and palmar epidermis by immunohis-
tochemistry as well as by RT-PCR. As many as 10 of 11 tested
connexins were detected in human epidermis. Immunolocalization
revealed a differentiation-speci®c pro®le of connexin expression
with distinct, yet overlapping, pattern for different connexin types.
The basal cell compartment showed only comparatively weak
expression of Cx26 and Cx43. Early differentiation of suprabasal
keratinocytes seemed to associate with a switch to the expression of
Cx43, Cx40, Cx45, and Cx32, whereas Cx31 expression appears as
a marker of late differentiation in the upper spinous and granular
cell layers. Cx26 and Cx30 were found predominantly in palmar
epidermis, con®rming the previously observed site-speci®city of
connexin distribution. Although not all epidermal connexins were
included (e.g., Cx30.3, Cx31.1, Cx37, and some more recently
discovered connexins) and the broad expression of Cx32 seems
incongruous with previous studies and might need con®rmation,
the new data by Di et al are fundamental for understanding the
physiologic function of gap junctions and intercellular commu-
nication in epidermal differentiation as well as the pathomechan-
isms of connexin disorders of the skin.
Atopic Dermatitis ± Development of a Transgenic Animal Model
Atopic dermatitis (AD), a common skin disease characterized by
chronic pruritic in¯ammation, signi®cantly impacts on the quality
of patients' lives. Although clinically easily recognizable by an
astute clinician, effective and speci®c treatment modalities have
been developed only recently. The pathogenesis of AD has
remained controversial, but the immune system in the skin is
clearly perturbed, including hyperactivation of T helper cell subset
2 (Th2) immune response. Based on this postulate, Chan et al (p.
977) have developed a transgenic mouse that expresses interleukin-
4 (IL-4), the critical Th2 cytokine, controlled by the keratin 14
promoter, which directs the expression into the basal keratinocytes
of the epidermis. Indeed, RT-PCR was able to demonstrate high
levels of IL-4 mRNA transcripts in transgenic mice as compared
with their nontransgenic littermates. Remarkably, at the age of
approximately 4 mo, the mice expressing the IL-4 transgene began
to develop an apparently pruritic, eczematous dermatitis with
clinical and histopathologic features reminiscent of AD.
Furthermore, the onset of the skin disease was associated with a
concurrent elevation of IgE and IgG1, and the total serum IgE
remained at high levels during the progression of the disease. In
fact, the phenotypic manifestations of these mice, together with
pathologic and immunologic ®ndings, ful®l the clinical diagnostic
criteria established for human AD. The authors describe their
mouse model as a ``pruritic in¯ammatory skin disease'', and
appropriately indicate that validation of this model as a mouse
counterpart of human AD requires further work. Nevertheless, the
availability of this transgenic mouse model should facilitate
investigation of the relationships between immunologic perturba-
tions and skin manifestations in pruritic in¯ammatory dermatoses in
general, and provides a murine model to test potential treatment
modalities for this group of common disorders.
A Cause of Spongiosis Revealed
Spongiosis is a prominent histologic feature of in¯ammatory skin
disorders characterized by widening of the intercellular spaces
between keratinocytes accompanied by cellular condensation. In
this issue, Trautmann et al (p. 927) demonstrate that, in eczematous
dermatitis, spongiosis is linked to proteolytic cleavage and
functional inactivation of E-cadherin which occurs as a conse-
quence of keratinocyte apoptosis. Interestingly, keratinocyte
apoptosis and attendant E-cadherin cleavage could be induced in
vitro by activated T lymphocytes and was dependent on Fas/CD95
activation. These results provide tantalizing evidence for immune-
mediated keratinocyte death, executed by activation of death
receptors, as a mechanism for spongiotic changes in the skin.
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NF-kB ± Holding Death Receptors in Check
Qin et al (p. 898) focus on mechanisms that attenuate the
deleterious consequences of death receptor activation in keratino-
cytes. Using a dominant-negative inhibitor of NF-kB activity in
normal keratinocytes they describe that NFkB serves to suppress
expression of several key effector molecules of death receptor
signaling; these include the adaptor molecules TRADD and
FADD, and the death receptor TRAIL-R1(DR4). Conversely,
expression of the inhibitor of apoptosis (IAP)-2 and of decoy death
receptors is induced by NF-kB activation. Collectively, NF-kB
activation thus appears to shift the expression patterns of pro- and
antiapoptotic death effectors in normal keratinocytes in favor of cell
survival. These results highlight that keratinocytes can mount a
formidable defense to activation of death receptors either in the
context of immune or in¯ammatory processes or through UV
radiation, situations which involve activation of NF-kB.
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